United Therapeutics Corp

NAS:UTHRHealthcareNASDAQ:NBINASDAQ:NQUSMG

$547.77+0.85%LiveIn session · ≈ AED 2,011.69 · Market cap $23.49B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	92.7%	92.7%	92.4%	88.9%	89.2%	87.9%	—	—
Operating margin	40.0%	33.0%	50.6%	50.9%	47.9%	47.7%	47.7%	+0.0 pts
Net margin	34.7%	28.2%	37.6%	42.3%	41.5%	41.9%	41.9%	+0.0 pts
EBITDA margin	43.6%	43.7%	53.7%	59.6%	57.5%	57.2%	—	—
Return on equity	15.2%	12.0%	15.2%	16.5%	18.5%	18.8%	18.8%	+0.0 pts
Return on assets	11.2%	9.2%	12.0%	13.7%	16.2%	16.9%	16.9%	+0.0 pts
Return on capital employed	13.8%	11.4%	17.2%	18.6%	20.8%	20.7%	—	—
Debt / equity	0.2×	0.2×	0.2×	0.1×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	17.3%	15.5%	13.2%	9.8%	4.1%	0.5%	—	—
Interest coverage	25.3×	29.9×	30.2×	20.0×	32.1×	77.8×	—	—
Current ratio	6.7×	7.6×	9.8×	4.4×	5.2×	6.6×	6.6×	+0.0%
Quick ratio	6.4×	7.3×	9.6×	4.3×	5.0×	6.3×	—	—
Cash ratio	2.3×	2.9×	2.8×	1.5×	2.3×	2.8×	2.8×	+0.0%
Asset turnover	0.3×	0.3×	0.3×	0.3×	0.4×	0.4×	—	—
Inventory turnover	1.2×	1.3×	1.4×	2.3×	2.0×	2.1×	—	—
Receivables turnover	9.4×	8.5×	8.8×	8.3×	10.3×	9.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.